Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Topical Tranexamic Acid in Hip Fractures
NCT02993341Phase 3Completed
- Sponsor
- Sault Area Hospital
- Start
- Nov 2016
- Primary completion
- Mar 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial of tranexamic acid in hip fracture (2 arms), sponsored by Sault Area Hospital. Primary endpoint: Change in hemoglobin. Started Nov 2016; status: completed.
02
Drugs
tranexamic acid
03
Conditions
hip fracture
Beyond the preview
Go deeper on NCT02993341.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02993341.